This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Novozymes-Chr Hansen deal clears US hurdle, still needs to be notified in at least Brazil, China, EU

By Flavia Fortes ( March 28, 2023, 21:13 GMT | Insight) -- Danish food ingredient and enzyme makers Novozymes and Chr Hansen announced that their proposed deal cleared a key US antitrust hurdle today. But the deal still needs approval from several jurisdictions, including at least Brazil, China and the European Union, MLex has learned.Danish food ingredient and enzyme makers Novozymes and Chr Hansen announced that their proposed deal cleared a key US antitrust hurdle today....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login